Maldives vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin
Maldives
46
in 2021
Trinidad and Tobago
57
in 2021
Maldives rank
123rd
Trinidad and Tobago rank
120th
The number of people with susceptibility test result for rifampicin over time
- Maldives
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 57 against 46 in Maldives, a difference of 11.
That makes Trinidad and Tobago's figure about 1.2 times Maldives's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Trinidad and Tobago ahead.
Maldives ranks 123rd and Trinidad and Tobago ranks 120th of 155 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Maldives | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76 | 102.67 | 26.67 | Trinidad and Tobago |
| 2020s | 44.5 | 74.5 | 30 | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Maldives or Trinidad and Tobago?
- Trinidad and Tobago, at 57 against 46 in Maldives as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Maldives and Trinidad and Tobago?
- 11, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Maldives and Trinidad and Tobago?
- 5 years are reported by both, from 2017 to 2021.
- How do Maldives and Trinidad and Tobago rank globally for the number of people with susceptibility test result for rifampicin?
- Maldives ranks 123rd and Trinidad and Tobago ranks 120th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.